End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12,890 ARS | +2.77% | +10.48% | +38.11% |
22/05 | Sandoz: Marketing authorization for Wyost and Jubbonti in the EU | CF |
22/05 | Roche Gets US FDA Breakthrough Designation For Lipoprotein(a) Test | MT |
Chart: Technical Analysis
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- AMGN Stock
- AMGN Stock
- Charts Amgen Inc.